Daewoong Pharmaceutical Co., Ltd (KRX: 069620)

Daewoong Pharmaceutical Revenue

Daewoong Pharmaceutical had revenue of 358.47B KRW in the quarter ending September 30, 2024, with 5.16% growth. This brings the company's revenue in the last twelve months to 1.42T, up 5.62% year-over-year. In the year 2023, Daewoong Pharmaceutical had annual revenue of 1.38T with 7.44% growth.

• Revenue (ttm): 1,416.63B
• Revenue Growth: +5.62%
• P/S Ratio: 1.01
• Revenue / Employee: 820.28M
• Employees: 1,727
• Market Cap: 1,435.98B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	1,375.33B	95.24B	7.44%
Dec 31, 2022	1,280.09B	127.12B	11.03%
Dec 31, 2021	1,152.98B	97.55B	9.24%
Dec 31, 2020	1,055.42B	-58.00B	-5.21%
Dec 31, 2019	1,113.43B	82.00B	7.95%